All-cause community acquired pneumonia cost by age and risk in real-world conditions of care in Spain

References

• Torres A, Barberán J, Falguera M, et al.; Grupo de la Guía Multidisciplinar para el Manejo de la Neumonía Adquirida en la Comunidad. Multidisciplinary guidelines for the management of community-acquired pneumonia. Med Clin (Barc). 2013;140:223.e1–e19.
   PubMedGoogle Scholar
• Regunath H, Oba Y. Community-acquired pneumonia. Treasure Island (FL): StatPearls Publishing; 2020. StatPearls [Internet]
   Google Scholar
• Lim WS, Baudouin SV, George RC, et al. BTS guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009;64(Suppl 3):iii1–iii55.
   PubMed Web of Science ®Google Scholar
• Choby BA, Hunter P. Respiratory infections: community-acquired pneumonia. FP Essent. 2015;429:11–21.
   PubMedGoogle Scholar
• Naucler P, Henriques-Normark B, Hedlund J, et al. The changing epidemiology of community-acquired pneumonia: nationwide register-based study in Sweden. J Intern Med. 2019;286(6):689–701.
   PubMed Web of Science ®Google Scholar
• Rivero-Calle I, Pardo-Seco J, Aldaz P, et al. NEUMOEXPERTOS Group. Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project). BMC Infect Dis. 20167;16(1):645. Erratum in: BMC Infect Dis. 2017 Jan 12;17 (1):64.
   PubMedGoogle Scholar
• Pérez-Deago B, Alonso-Porcel C, Elvira-Menendez C, et al., Epidemiology and management of community acquired pneumonia: more than 10 years’ experience. Semergen. 44(6): 389–394. 2018.
   PubMedGoogle Scholar
• McLaughlin JM, Khan FL, Thoburn EA, et al. Rates of hospitalization for community-acquired pneumonia among US adults: a systematic review. Vaccine. 2020;38(4):741–751.
   PubMed Web of Science ®Google Scholar
• Postma DF, van Werkhoven CH, Oosterheert JJ. Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelines. Curr Opin Pulm Med. 2017;23(3):204–210.
   PubMed Web of Science ®Google Scholar
• Rivero-Calle I, Pardo Seco J, Raguindin PF, et al. Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain. Hum Vaccin Immunother. 2019;18:1–8.
   Google Scholar
• Chacón García A, Ruigómez A, García Rodríguez LA. Incidence rate of community acquired pneumonia in a population cohort registered in BIFAP. Aten Primaria. 2010;42(11):543–549.
   PubMed Web of Science ®Google Scholar
• Irizar Aramburu MI, Arrondo Beguiristain MA, Insausti Carretero MJ, et al. Epidemiology of community-acquired pneumonia. Aten Primaria. 2013;45(10):503–513.
   PubMed Web of Science ®Google Scholar
• Viasus D, Del Rio-Pertuz G, Simonetti AF, et al. Biomarkers for predicting short-term mortality in community-acquired pneumonia: a systematic review and meta-analysis. J Infect. 2016;72(3):273–282.
   PubMed Web of Science ®Google Scholar
• Welte T. Risk factors and severity scores in hospitalized patients with community-acquired pneumonia: prediction of severity and mortality. Eur J Clin Microbiol Infect Dis. 2012;31:33–47.
   PubMed Web of Science ®Google Scholar
• Tazon-Varela MA, Alonso-Valle H, Muñoz-Cacho P, et al. Aumento de microorganismos no habituales en la neumonía adquirida en la comunidad. Semergen. 2017;43(6):437–444.
   PubMedGoogle Scholar
• Redondo E, Rivero-Calle I, Vargas DA, et al. Adult community acquired pneumonia vaccination: 2018 Update of the positioning of the pneumonia prevention expert group. Semergen. 2018;44(8):590–597.
   PubMedGoogle Scholar
• Kaplan A, Arsenault P, Aw B, et al. Vaccine strategies for prevention of community-acquired pneumonia in Canada: who would benefit most from pneumococcal immunization? Can Fam Physician. 2019;65(9):625–633.
   PubMed Web of Science ®Google Scholar
• Heo JY, Song JY. Disease burden and etiologic distribution of community-acquired pneumonia in adults: evolving epidemiology in the era of pneumococcal conjugate vaccines. Infect Chemother. 2018;50(4):287–300.
   PubMed Web of Science ®Google Scholar
• Torres A, Cillóniz C, Blasi F, et al. Burden of pneumococcal community-acquired pneumonia in adults across Europe: a literature review. Respir Med. 2018;137:6–13.
   PubMed Web of Science ®Google Scholar
• Sicras-Mainar A, Ibáñez-Nolla J, Cifuentes I, et al. Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain). BMC Infect Dis. 2012;12(1):283.
   PubMed Web of Science ®Google Scholar
• Divino V, Schranz J, Early M, et al. The annual economic burden among patients hospitalized for community-acquired pneumonia (CAP): a retrospective US cohort study. Curr Med Res Opin. 2020;36(1):151–160.
   PubMed Web of Science ®Google Scholar
• Sicras-Mainar A, Enríquez JL, Hernández I, et al. Validation and representativeness of the Spanish BIG-PAC database: integrated computerized medical records for research into epidemiology, medicines and health resource use (REAL WORD EVIDENCE). Value Health. 2019;22(Supplement 3):S734.
   Google Scholar
• Centers for Medicare & Medicaid Services. 2013 Measures updates and specifications report: hospital-level 30-day risk-standardized readmission measures for acute myocardial infarction, heart failure, and pneumonia (Version 6.0). Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/HospitalQualityInits/Measure-Methodology.html (Cited 2020 Mar 09)
   Google Scholar
• Grupo de trabajo vacunación en población adulta y grupos de riesgo de la Ponencia de Programa y Registro de Vacunaciones. Vacunación en grupos de riesgo de todas las edades y en determinadas situaciones. Comisión de Salud Pública del Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad, Consumo y Bienestar Social, July 2021. https://www.mscbs.gob.es/profesionales/saludPublica/prevPromocion/vacunaciones/programasDeVacunacion/riesgo/docs/VacGruposRiesgo_todas_las_edades.pdf. Date last update: 24 July 2018. Date last accessed: 09 July 2021** A paper of considerable importance in Spain regarding the state of the art in vaccination recommendations in the adult population.
   Google Scholar
• Personne V, Chevalier J, Buffel Du Vaurea C, et al. CAPECO: cost evaluation of community acquired pneumonia managed in primary care. Vaccine. 2016;34(19):2275–2280.
   PubMed Web of Science ®Google Scholar
• Saba G, Andrade LF, Gaillat J, et al. Costs associated with community acquired pneumonia in France. Eur J Health Econ. 2018;19(4):533–544.
   PubMed Web of Science ®Google Scholar
• Campling J, Jones D, Chalmers J, et al. Clinical and financial burden of hospitalized community-acquired pneumonia in patients with selected underlying comorbidities in England. BMJ Open Respir Res. 2020;7(1):e000703.
   PubMed Web of Science ®Google Scholar
• Kosar F, Alici DE, Hacibedel B, et al. Burden of community-acquired pneumonia in adults over 18 y of age. Human Vaccines Immunother. 2017;13(7):1673–1680.
   PubMed Web of Science ®Google Scholar
• Vissink CE, Huijts SM, Ardine de Wit G, et al. Hospitalization costs for community acquired pneumonia in Dutch elderly: an observational study. BMC Infect Dis. 2016;16(1):466.
   PubMedGoogle Scholar
• Ferreira-Coimbra J, Sarda C, Rello J. Burden of community-acquired pneumonia and unmet clinical needs. Adv Ther. 2020;37(4):1302–1318.
   PubMed Web of Science ®Google Scholar
• Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe Thorax. Thorax. 2012;67(1):71–79.
   PubMed Web of Science ®Google Scholar
• Chalmers J, Campling J, Ellsbury G, et al. Community-acquired pneumonia in the United Kingdom: a call to action. Pneumonia. 2017;9(1):15.
   Google Scholar
• Antunes C, Pereiraa M, Rodrigues L, et al. Hospitalization direct cost of adults with community-acquired pneumonia in Portugal from 2000 to 2009. Pulmonology. 2020;26(5):264–267.
   PubMed Web of Science ®Google Scholar
• European Respiratory Society. Pneumonia. In: European lung white book 2 edn ed. Sheffield: European Respiratory Society/European Lung Foundation; 2003. p. 55–65.
   Google Scholar
• Sato R, Gomez Rey G, Nelson S, et al., Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥ 50 Years. Appl Health Econ Health Policy. 11(3): 251–258. 2013.
   PubMedGoogle Scholar
• Choi MJ, Song JY, Noh JY, et al. Disease burden of hospitalized community-acquired pneumonia in South Korea: analysis based on age and underlying medical conditions. Medicine (Baltimore). 2017;96(44):e8429.
   PubMed Web of Science ®Google Scholar
• Fernando Saldías P, Fernando Román OA, Rolando Maturana OA, et al. Predictores clínicos de mortalidad en el seguimiento a mediano plazo en pacientes adultos inmunocompetentes hospitalizados por neumonía adquirida en la comunidad. Rev Med Chile. 2013;141(2):143–152.
   PubMedGoogle Scholar
• Sato R, Weycker D, Shaff M. Mortality and readmission in adults during the first year following hospitalization for community-acquired pneumonia in the US. IDWeek 2020.
   Google Scholar
• Population Study of Pneumonia (PSoP) Group, Capelastegui A, España PP, Bilbao A, et al. Study of community-acquired pneumonia: incidence, patterns of care, and outcomes in primary and hospital care. J Infect. 2010;61(5):151–160.
   Web of Science ®Google Scholar
• Ramirez JA, Wiemken TL, Peyrani P, et al. Adults hospitalized with pneumonia in the United States: incidence, epidemiology, and mortality. Clin Infect Dis. 2017;65(11):1806–1812.
   PubMed Web of Science ®Google Scholar
• Bjarnason A, Westin J, Lindh M, et al. Incidence, etiology, and outcomes of community-acquired pneumonia: a population-based study. Open Forum Infect Dis. 2018;5(2):ofy010.
   PubMed Web of Science ®Google Scholar
• Ewig S, Giesa C. Update: guidelines for the treatment and prevention of adult community-acquired pneumonia 2016: what is new? MMW Fortschr Med. 2017;159(3):51–52.
   PubMedGoogle Scholar
• Menéndez R, Cilloniz C, España PP, et al., Community-acquired pneumonia. Spanish society of pulmonology and thoracic surgery (SEPAR) guidelines. 2020 update. Arch Bronconeumol. 56(Suppl 1): 1–10. 2020.
   Google Scholar
• Gajewska M, Goryński P, Paradowska-Stankiewicz I, et al. Monitoring of community-acquired pneumonia hospitalizations before the introduction of pneumococcal conjugate vaccine into polish national immunization programme (2009–2016): a nationwide retrospective database analysis. Vaccine. 2020;38(2):194–201.
   PubMed Web of Science ®Google Scholar
• Isturiz RE, Ramirez J, Self WH, et al. Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia. Vaccine. 2019;37(25):3352–3361.
   PubMed Web of Science ®Google Scholar
• Montes-Andujar L, Tinoco E, Baez-Pravia O, et al. Empiric antibiotics for community-acquired pneumonia in adult patients: a systematic review and a network meta-analysis. Thorax. 2021;76(10):1020–1031.
   PubMed Web of Science ®Google Scholar
• Vila-Corcoles A, Bejarano-Romero F, Salsench E, et al. Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia. BMC Infect Dis. 2009;9(1):36.
   PubMedGoogle Scholar
• Woodhead M, Blasi F, Ewig S, et al., Guidelines for the management of adult lower respiratory tract infections. Clin Microbiol Infect. 17 Suppl 6(Suppl. 6): E1–E59. 2011.
   PubMedGoogle Scholar